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The neoplasm, although mainly a typical squamous type, showed a definite
tendency to gland-like arrangement associated with much extracellular mucus.
Variation in cell type is, of course, a recognized feature of many bronchogenic
growths. Attention has frequently been drawn to the presence of squamous
metaplasia in lung fibrosis and its possible relation to a squamous carcinoma.
Inthis case noevidence ofsquamous metaplasia was found, although many blocks
of tissue were examined. Homburger found only one instance of metaplasia
occurring in pneumoconioses, and considers it a very doubtful indication that
asbestosis predisposes to carcinoma. The literature is fully reviewed in his
article.
I should like to express my grateful thanks to Professor Geoffrey Hadfield
and to Professor Sir Ernest Kennaway for their criticisms and great help, and
also to Messrs. A. Harvey and A. Young of the Department of Pathology, Royal
Victoria Infirmary, for invaluable technical assistance.
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IN the course of experiments on a transplantable mouse sarcoma it was
observed that fresh saline extracts of tumour tissue agglutinated mouse and
rabbit red cells. When extract and red cell suspension were mixed on a slide
agglutination became visible to the naked eye within 30 seconds and appeared to
be complete within 2 minutes.
A number of different mouse and rat tumours, and a wide range of normal
tissues, have been examined for haemagglutinating activity. The agglutinability
of various species of red cells has been tested. Some physical and chemical
properties of the haemagglutinating agents have been investigated.M. H. SALAMAN
Materials and methods.
Tumours.-
Mouse: 1. C57 sarcoma. 2. C57/LH1 sarcoma. 3. S37 sarcoma.
4. Crocker 180 sarcoma. 5. C57 X mammary adeno-carcinoma. 6.
C57 A mammary adeno-carcinoma. 7. D13 thymoma.
Rat: 8. Walker 256 carcinoma. 9. Hepatoma.
Origin: No. 1, 2, and 6 were induced by methylcholanthrene. No. 3
arose as a sarcomatous transformation of stroma in a spontaneous carci-
noma. No. 5 was induced by foster-nursing. No. 7 was a spontaneous
tumour. No. 9 was induced by feeding butter-yellow. (Primary tumour
only examined.)
Maintenance: No. 1, 2, 5, 6, and 7 were maintained by serial trans-
plantation in C57 black mice, No. 3 and 4 in stock mice, and No. 8 in
stock rats.
Preparation of extracts.-Tissue was ground in a "Tenbroeck" type grinder
with Ringer, or buffered saline, to give 10 or 20 per cent suspensions. These
were centrifuged at moderate speed; the supemrnatant fluids contained the
haemagglutinating agents.
Preparation of red cell suspensions.-Blood of various species was taken from
a vein, or from the heart, into citrate solution, centrifuged, twice washed, and
finally suspended in normal saline containing 0.024 per cent CaCl2 (Burnet and
Anderson, 1946). Commercial preparations of horse and sheep blood were used
as sources of red cells of these species.
Haemagglutination tests.-Slide agglutination was used whenever qualitative
information only was wanted, because ofits simplicity and speed. When quanti-
tative results were required a tube test based on that used by Burnet and his
co-workers (Burnet, Beveridge, McEwin and Boake, 1945) was adopted.
Serial two-fold dilutions of tissue extract were made in calcium-saline in
round-bottomed tubes of approximately 0-8 cm. internal diameter. Each tube
received 0.1 c.c. of diluted extract and 0.05 c.c. of a 2 per cent suspension of
washed red cells in calcium-saline; the tubes were then shaken and allowed to
stand at room temperature for 20-30 minutes. A preliminary reading of the
end-point could then be made, if a quick answer was needed, which did not
differ by more than one place from the final reading. Calcium-saline, 0-3 c.c.,
was then added, the tubes were shaken and allowed to stand a further 1 hours
at room temperature, when the final reading was made.
The type of agglutination, and also of the deposition of red cells in saline
controls, varied with species. Mouse cells seldom, and rabbit cells hardly ever,
gave the compact button of deposit which is typical of unagglutinated fowl or
human cells, and which workers with influenza virus haemagglutination take as
negative. Rabbit cells, in the absence of an agglutinating agent, settle in a
round-bottomed tube as an ill-defined deposit surrounded by a slightly granular
film, which would be regarded as evidence of agglutination of fowl cells. It
resembles closely the "shield pattern " which has been described (Burnet and
Stone, 1946) as typical of agglutination of fowl cells by lipoids. Mouse cells,
when unagglutinated, usually settle partly as a film, partly as a button or ring.
In these tests, the last tube which showed granularity of the deposit definitely
coarser than that of a saline control was taken as the end point. Higher con-
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centrations ofhaemagglutinating agent caused the cells to coalesce into a reticular
coagulum, which, on shaking, broke up into long shreds and large flakes floating
in a clear fluid.
Very little haemolysis was seen, unless the test was allowed to stand for long
periods at room temperature (24-48 hours) or was carried out at 37° C.
Preservation of haemagglutinating agent.
The haemagglutinating power oftumour extracts declinedrapidly on standing.
In the case of the C57 sarcoma, activity fell to about one-half its original value
in an hour and had usually disappeared after 24 hours, at room temperature.
Activity of other tumour extracts declined more rapidly.
An attempt was made to determine the cause of this decline of activity,
and to find means ofpreventing it. The effect ofadding various enzyme poisons
to fresh tumour extracts was tried. Neither sodium azide (0-08 per cent), nor
sodium iodoacetate (0.0001 to 0.003 M), nor sodium cyanide (0.002 M, neutralized),
prevented or delayed the decline of haemagglutinating power of an extract of
C57 sarcoma. Antoxidants were then tried. Ascorbic acid (0.01 M, neutralized),
hydroquinone (0.01 M), and bright iron, were ineffective. Decline of activity
was as rapid in an oxygen-free atmosphere (McIntosh and Fildes jar) as in air.
SH compounds, however, had a definite retarding effect on the decline. Cysteine
and glutathione (0.01 M, neutralized) both appeared to retard the decline of
haemagglutinating activity appreciably, but their effect was difficult to estimate
because they had slight haemagglutinating action themselves. Sodium thio-
glycollate (0-01 M) and 2,3 dimercapto propanol (British Anti-Lewisite, or
B.A.L., 0.01 M) were much more powerful as preservatives and had no haemagglu-
tinating action of their own. Both preserved the activity of tumour extracts
at a constant level for long periods. Thioglycollate was found to be fairly
rapidly haemolytic, even in high dilution (0.001 M or higher). B.A.L. proved a
very satisfactory preservative. It was effective in low concentration (0.005 M),
and though it increased slightly the granularity of deposits ofred cells in control
tubes, it had no haemagglutinating action which could be confused with that of
tumour extracts, even in concentrations much higher than this. It was slowly
lytic for mouse red cells (though this did not interfere with tests read after the
usual period of two hours) but not for those of other species. A final concentra-
tion of 0 01 M (0 12 per cent) was generally used; this was conveniently obtained
by adding to a tumour extract 1/50th of its volume of a saturated aqueous
solution of B.A.L. (approximately 6 per cent).
Besides preventing loss of activity of fresh extracts, B.A.L. brought about
regeneration of the activity of inactive extracts to their original titre. This
regeneration was progressive: some activity was apparent in a previously
inactive extract a few seconds after the addition of B.A.L., but the full titre
was not reached for about an hour, at room temperature.
Table I shows the preservation by B.A.L. of the haemagglutinating power
of a C57 sarcoma extract for rabbit red cells.
Further observations on the action of B.A.L. are recorded in later sections.
Species range of haemagglutination.
No significant differences in agglutinability were found between red cells of
normal and tumour-bearing mice, or between mice of different breeds. Red
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cells of other species were agglutinated by tumour extracts in varying degree.
The addition of sodium thioglycollate or B.A.L. to a tumour extract did not
alter the species range of its agglutinating action.
TABLE I.-Preservative and Regenerative Action of B.A.L. on the
Haemagglutinating Power of a Sarcoma Extract.
C57 sarcoma extract.
Containing B.A.L. 0.01 M, after standing 45 mins. at room temperature . 64
,,,, ,, ,, 4 hours ,, ,, . 128
,,,, ,, ,, 25 ,, ,, ,, . 64
Not containing B.A.L., after standing 45 mins. at room temperature . 32
~,, ,, ,, 4hours ,, ,, . 8
25 ,, ,, . 1
B.A.L. 0.01 M added after standing 25 hours at room temperature . . 64
Figures represent reciprocals of haemagglutinating titres for rabbit red cells.
Table II shows the results of agglutination tests between a C57 sarcoma
extract and mouse, rat, guinea-pig, rabbit, horse, sheep, human, and fowl cells.
TABLE II.-Agglutination of Various Species of Red Cells by a C57
Sarcoma Extract Containing B.A.L. 0.01 M.
Red cell species.
, A-~~~~~~~~~~~~~~~.
Human Fowl, Fowl,
Mouse. Rat. Guinea- Rabbit. Horse. Sheep. Group lipoid- lipoid non-
pig. . agglutin- agglutin-
able. able.
Reciprocal of
agglutinat-
ing titre . 8 . UIn-. 2 .128. 2 4 . 2 2 . 2
stable
Lipoid suspensions, such as Kahn antigen, have been shown to agglutinate the
red cells of some fowls, but not of all (Burnet and Stone, 1946). Fowl cells of
each type, distinguished by a previous test against Kahn antigen, were included
in this test.
It will be seen that rabbit cells were agglutinated by the tumour extract to
far higher titre than those of any other species tried. Lipoid agglutinable and
lipoid non-agglutinable fowl cells were agglutinated to the same low titre.
Tumour extracts varied somewhat with regard to the ratio between titres for
different red cells, but these variations were not constant. The titre for rabbit
cells was always between 4 and 16 times the titre for mouse cells. Extracts
treated in various ways, to be described later, were tested in most cases against
rabbit and mouse cells. No significant alterations of the ratio of rabbit cell to
mouse cell titres were observed.
Occurrence ofhaemagglutinating agents in various tumours.
Besides C57 sarcoma, other tumours, listed on p. 254, were examined for
haemagglutinating agents.
The haemagglutinating titres of extracts of these tumours varied greatly
(Table III). The sarcomata gave higher titres than the carcinomata.
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TABLE III.-Haemagglutinating Titres of 20 per cent Extracts of Variou$
Mouse and Rat Tumours.
Red cells.
Rabbit. Mouse.
C57 mouse sarcoma . . . 32 to 256 . 8 to 64
C57/LH1 mouse sarcoma . . . 16 ,, 64
S37 mouse sarcoma . . . . 4 ,, 64 . 2 to 16
Crocker 180 mouse sarcoma . . . ++++ + . + ++
D13 mouse thymoma . . . . 1 to 8 . () to 2
C57X mouse mammary carcinoma . 2 . 0
C57A ,, 2 .
Walker 256 rat carcinoma . . . ++++ + . ++
Butter yellow rat hepatoma. . . 8 . 1
Figures represent reciprocals of titres in the tube test.
- to + + + + represent degrees of agglutination in the slide test.
All extracts contained B.A.L. 0.01 M.
C57 and S37 sarcoma extracts were compared in respect of red cell species
range. They differed only in a manner which could be accounted for as a pro-
portionately lower titre of S37 extracts for all species, e.g. red cells which were
agglutinated to low titre by C57 were inagglutinable by S37 extracts.
Extracts of all the tumours tested lost their activity on standing, though at
varying rates, e.g. extracts of C57 sarcoma took about 24 hours to become
inactive, but extracts of C57/LH1, sarcoma, though initially often of similar
titre, became inactive in one hour, or less. The loss could be prevented, or
reversed, by the addition of B.A.L.
Occurrence and distribution of haemagglutinating agent in normal tissue.
Extracts of mouse liver, spleen, kidney, heart, lung, brain, voluntary muscle,
lymph gland and thyroid, derived from both normal and tumour-bearing mice,
were found not to agglutinate mouse red cells; and for a time it was thought
that the haemagglutinating agent was confined to tumours. Examination of a
wider range of normal tissues, using rabbit as well as mouse red cells, showed
that this was not so.
Extracts of several tissues, notably adult mouse testicle, ovary, uterus and
voluntary muscle, as well as whole mouse embryo and placenta, agglutinated
rabbit red cells and sometimes mouse red cells also. The haemagglutinating
titres of these extracts were, in general, low compared with those of extracts of
mouse sarcomata, but comparable with those of extracts of some of the other
tumours examined. Table IV gives the range of haemagglutinating titres for
rabbit, mouse and human red cells, of a number of normal tissue extracts. The
haemagglutinating power of these extracts declined on standing, and was pre-
served, or regenerated, by the addition of B.A.L. in the same way as that of
tumour extracts (Table V). Their species range of haemagglutination showed
no difference from that oftumour extracts which could not be accounted for as a
proportionately lower titre for all species.
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TABLE IV.-Haemagglutinating Titres of 20 per cent Extracts of Normal
Mouse Tissues.
Red cells.
Positive Rabbit. Mouse. Human.
Uterus, oestrous . . . . 32 . 4 . 0
dioestrous . . . . 8 . 2 . 0
,, anoestrous . . . 8 . 2 . 0
Whole embryo, 19-20th day . . 8 . 1 . 0
Placenta ,, ,, . . 8 . 1 . 0
Testicle . . . . 4 . 0 . 0
Ovary . . . . . . 2 . 0 . 0
Voluntary muscle . . . . 8 . 0 . 0
Skin . . . . . . 4 . 0 . 0
Large intestine . . . . 8 . 0 . 0
Negative:
Brain, heart, lung, liver, spleen, kidney, thyroid, seminal vesicles,
lymph-gland. Stomach and small intestine extracts were too
strongly haemolytic for testing.
All extracts contained B.A.L. 0.01 M.
Figures represent reciprocals of titres.
TABLE V.-Preservative and Regenerative Action of B.A.L. on the
Haemagglutinating Power of Mouse Embryo Extract.
Extract of 20-day embryos.
Containing B.A.L. 0.01 M, after standing 45 mins. at room temperature . 8
,, ,, 7, ,, 22 hours ,, ,, . 8
Not containing B.A.L., after standing 45 mins. at room temperature . . 4
,, ,, 7 , 2 hours ,, ,, . . 0 , ,, 7,, 22 ,, ,, ,, . . 0
B.A.L. 0-01 M added after standing 22 hours at room temperature . . 8
Figures represent reciprocals ofhaemagglutinating titres for rabbit red cells.
Someotherpropertiesof the haemagglutinating agents of tumrnours and normal tissues.
Action of normal serum on haemagglutination.-Haemagglutination by lipoids
is inhibited by normal serum in high dilution, while haemagglutination by viruses
is unaffected by normal sera, but inhibited by specific antiviral sera (Burnet and
Stone, 1946).
The effect of normal horse serum on haemagglutination by tumour and
normal tissue extracts was tested. Extracts were mixed with equal volumes of
a 1 in 100 dilution ofhorse serum, and the mixtures tested for haemagglutination
in the usual way. No inhibition was observed.
Action of sera of mice in which tumrnours had regressed on haemagglutination.
S37 sarcomagraftsgrowfor atimein C57 black mice andthenregress. Similarly,
C57 sarcoma grafts grow for a time and then regress in stock albino mice. Serum
was collected from four C57 black mice 26 days after grafting with S37 sarcomaHAEMAGGLUTINATION BY EXTRACTS OF TUMOURS
and from four stock albino mice 23 days after grafting with C57 sarcoma, at
which times only small residual nodules remained. An experiment similar to
the last showed that addition of either of these sera had no effect on haemagglu-
tination by either C57 or S37 sarcoma extracts.
Effect of temperature at which the test is performed on haemagglutination.-It
has been shown that haemagglutination by lipoids and by vaccinia virus is
more active at 37° C. than at room temperature (Stone, 1946; Burnet and
Stone, 1946), while haemagglutination by influenza virus is more active in the
cold than at room temperature or 37° C. (Salk, 1944).
Haemagglutination by extracts of C57 and S37 sarcomata, and of normal
mouse embryo and adult uterus, was tested at approximately 4° C., at room
temperature, and at 37°C. The process of haemagglutination was actually
accelerated by increase oftemperature in all cases, but this did not result in a
higher titre as judged by reading after the usual two-hour period. Table VI
TABLE VI.-Effect on Haemagglutination of the Temperature at
which the Test is Performed.
Temperature of test.
Room
+ 40 C. temperature. 370 .
C57 sarcoma extract . . . . 64 . 64 . 32
S37 ,, ,, . . . . 32 . 32 . 16
Mouse embryo extract . . . 2 . 2 . 4
Mouse uterine ,, . . . 16 . 32 . 16
Figures represent reciprocals of haemagglutinating titres for rabbit cells.
All extracts contained B.A.L. 0.01 M.
shows that the titres of tumour extracts fell slightly with increase of tempera-
ture, a change in the same direction as that reported for influenza virus, though
much smaller. The slight variations shown in titre of normal tissue extracts at
different temperatures are probably not significant.
Neither tumour nor normal tissue extracts resemble lipoids in this respect.
Action of complement on haemagglutination.-A standard quantity of an
extract of C57 sarcoma (16 haemagglutinating doses) was tested against rabbit
and mouse red blood cells, with and without the addition of guinea-pig serum
(approximately 10 M.H.D. measured in a sheep cell-antisheep cell serum svstem).
The mixtures were held at 37° C. for I hour, then at 40 C. overnight. The
presence of complement had no detectable effect: neither rabbit nor mouse
cells were lysed and their agglutination by the tumour extract was unaffected.
Absorption of haemagglutinating agent by red cells.--C57 sarcoma extracts
were absorbed with rabbit, mouse, and fowl red cells, under various conditionts.
The following is a representative experiment.
Samples of 20 per cent extracts of C57 sarcoma, (i) fresh, i.e. 1 hour after
making, (ii) inactive, i.e. after standing overnight, and (iii) preserved by B.A.L.
(0.01 M) were absorbed with 1/10th of their volumes of packed rabbit, mouse,
and fowl red cells.
Mixtures (i) were held at room temperature for 30 minutes only, in order to
minimize possible re-dispersion ofthe red cells owing to decline of activity ofthe
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extract, and then centrifuged. Mixtures (ii) and (iii) were hleld at 4° C. over-
night, and then centrifuged. The supernatant. fluids were removed and the
cells re-suspended in the original volumes of saline. The re-suspended cells
were incubated at 37° C. for three hours, and centrifuged; the supernatant
fluids were removed and the cells finally resuspended in the original volumes of
saline, and examined for persistent agglutination and for agglutinability. B.A.L.
was added to 0.01 M to all the supernatant fluids and they were tested for
haemagglutinating power.
The results may be summarized as follows:
Haemagglutinating agent was absorbed by red cells when, and only when,
they were agglutinated by it. Rabbit and mouse cells, in the doses used,
absorbed about 3 of the haemagglutinating agent present in fresh, or in B.A.L.-
preserved extracts (i.e. extracts which agglutinated them strongly). Neither
absorbed any agent from an extract which had become inactive, though presence
of the agent in the extract was proved by subsequent addition of B.A.L. Fowl
cells, which were only very slightly agglutinated, did not absorb appreciably.
In allexcept one case red cells agglutinated during absorption were unsuitable
for subsequent tests for agglutinability because they remained agglutinated.
The exception was mouse cells used to absorb fresh extract. These, though
agglutinated in the presence of the extract (30 minutes at room temperature)
redispersed during the subsequent incubation with saline. They were then
found to be fully agglutinable by tumour extract containing B.A.L., but not by
B.A.L. alone. Mouse and rabbit cells which did not agglutinate during absorp-
tion, i.e. those used to absorb inactive extract, were also found to be subsequently
fully agglutinable by a B.A.L.-containing tumour extract, but not by B.A.L.
alone.
Since red cells after absorption, when they were suitable for subsequent
agglutination tests, proved agglutinable by the same tumour extract which
they had been used to absorb, it was not thought worth while to attempt cross-
agglutination between different extracts (e.g. those of different tumours, or of
tumour and normaltissues) and red cells used to absorb them.
Partial release of haemagglutinating agent occurred during incubation of
red cells in saline after absorption. Recovery was never complete but was most
nearly so in the case, noted above, ofmouse cells used to absorb fresh tumour
extract.
A good deal of haemolysis of agglutinated red cells occurred; this was
noticeable during absorption and during the subsequent incubation in saline.
Haemolysis is not appreciable in haemagglutination tests, and its appearance
in absorption mixtures was unexpected. The difference is probably quantitative.
Gross (1947) has reported the presence of haemolytic agents in several tumours.
Haemolysis by such an agent, if of low titre, would be active only in the first
one or two tubes of a haemagglutination test and, since these contain only
1/450th of their volume of packed red cells, haemolysis might be masked by the
smallamount ofhaemoglobin present in all crude tissue extracts. But in absorp-
tion mixtures consisting of undiluted extract and 1/10 volume of packed red
cells, even slight haemolysis would be obvious.
Filtration and dialysis.-The haemagglutinating agent of tumour extracts
containing B.A.L. passed through Gradocol membranes of A.P.D. 0.6 to 0.7V, andthrough Berkefeld V candles, with only slightloss ofactivity. 'Inthe absence
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of B.A.L., activity seemed to be lost even more rapidly during filtration than on
standing, but reappeared as usual after addition of B.A.L. to the filtrate. The
agent was not dialysable through cellophane.
At anearly stage inthis work, when it was thought, on the basis ofpreliminary
tests, that the haemagglutinating agent was confined to tumour tissue (p. 257),
a number of mice were injected with cell-free filtrates of tumour extracts con-
taining B.A.L., on the assumption that the haemagglutinating agent might be
associated with a labile filtrable tumour-producing agent.
Cell-free haemagglutinating filtrates of saline or broth extracts of C57, S37,
and Crocker 180 mouse sarcomata, containing B.A.L. 0.005 to 0.01 M, were
injected subcutaneously and intraperitoneally into groups of 4 to 8 mice of
appropriate breeds. In several cases mixtures of filtrate and mouse red cells
were injected. The mice were observed for 4 to 10 weeks. No tunours de-
veloped. To exclude the possibility that failure to produce tumours was due to
inhibition of growth by B.A.L., a piece of S37 sarcoma was minced in broth
containing 0.005 M B.A.L., and kept at 4° C. for 48 hours before grafting into
mice. Grafts of the same tumour minced and kept in plain broth were made
into control mice. Both groups developed tumours; those which grew from the
B.A.L.-treated grafts lagged behind at first but, by the eighteenth day, there
was no difference in size of tumours between the groups.
Centrifugation.-The haemagglutinating agent of a C57 sarcoma extract was
not deposited by centrifugation in an angle head at 9000 r.p.m. for 11 hours.
High speed centrifugation has not been tried.
Precipitation by ammonium sulphate.-The haemagglutinating activity of a
C57 sarcoma extract was associated with a fraction precipitated between J and
saturation with ammonium sulphate, and most ofit with a fraction precipitated
between I andi saturation.
Action of heat.-C57 sarcoma extract was heated at 55° C. for 30 minutes
and at 100° C. for 10 minutes. At pH between 7 and 8 the former treatment was
found to reduce the haemagglutinating titre to about half, the latter to about
one-eighth. At pH 6, and at pli 9, boiling for 10 minutes destroyed all activity.
There was no difference between titres of extracts to which B.A.L. had been
added before, and those to which it had been added after, heat treatment.
A heavy precipitate formed in the heated extract, which was spun out before
testing for haemagglutinating power, and it was thought possible that the
haemagglutinating agent might be adsorbed on the precipitate. However, no
agent could be recovered by extracting the precipitate with M/15 Na2HPO4.
Action of enzymes.-Trypsin and Papain. The effect of digestion of tumour
extracts by trypsin or papain depends on whether they contain B.A.L. In the
absence of B.A.L., extracts of C57, or of C57/LH1, sarcoma incubated at 37° C.
with trypsin or papain (activated with KCN) for an hour, were found to be
irreversibly inactivated, i.e. subsequent addition of B.A.L., even up to 0.1 M,
caused no return of haemagglutinating power. Addition of B.A.L. 0.01 M to
the extracts before digestion prevented any loss of haemagglutinating power
for at least 21 hours, but after 20 hours' digestion a considerable drop in titre
was observed, which was not reversible by further addition of B.A.L.
These results are illustrated in Table VII A, which records the effect of
digestion of C57 sarcoma extract by trypsin. Digestion bypapain had essentially
similar effects.
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TABLE VII.
A. Action of Trypsin on Haemagglutinating Agent of Sarcoma Extract, and its
Inhibition by B.A.L. Time ofincubation.
1 hour. 21 hours. 20 hours.
1. 20 per oent extract of C57 sarcoma, control . . . 16 . 8 . 4
2. The same + B.A.L. 0.005 M . . . . . 32 . 32 . 32
3. ,, + trypsin . . .0 . 0 . 0
4. ,, + ,, +B.A.L. 0005 M . . . . 32 16 . 4
5. ,, + ,, + ,, 0-01 M . . . 32 . 32 . 4
Conditions: Incubation 37° C. Trypsin0.5percentofcommercialpowder (Hopkins & Williams).
All mixtures buffered at pH 8 with M/15 phosphate, 2 drops of chloroform added as baoteriostatic;
neutralized, and B.A.L. added to 0.01 M, before test.
Figures represent reciprocals of haemagglutminating titres for rabbit red cells.
B. Proteolytic Action of Trypsin on Sarcoma Extract in Relation to its Action on
the Haemagglutinating Agent, and Inhibition of Both Actions by B.A.L.
Time ofincubation 21 hours.
· Haemagglutinating Mg. amino N pe r Haemagglutinatirng 5 c.c., excess over control.
1. 20 per cent extiact of C57 sarcoma, control . . . . 64 . -
2. The same + trypsin . . . . . . . . 0 . 3-43
3. ,, + ,, + B.A.L. 0005 M . . . 64 . 1.82
4. . + ,, + ,, 0.01 M . . . 64 . 1 61
Relevant conditions as in A.
C. Inhibition by B.A.L. of Tryptic Digestion of Casein.
Time ofincubation.
1 hour. 21 hours.
4 per cent solution ofcasein, Mg. amin N 1. + trypsin . . . . . . . 043 . 1-54 Mg. amio N
2. -+ ,, +B.A.L. 0.005 . . . 0.57 . 0-84 per 5 c.c., "....~~~~~~~~~~~~~~~~excessover
3. + ,, + ,, 0'01 M . . . . 0-43 . 0.56 control. ' '^ * ~~~~~~~~~~~~~~~~~~control.
Casein was "light, soluble" of British Drug Houses, dissolved in M/15 Na,HPO, by heating
1 hour on a water-bath.
Relevant conditions as in A.
It will be noted that there was a considerable irreversible drop in titre of a
control sample of sarcoma extract incubated without B.A.L. (Table VII A,
No. 1), while that of a similar sample incubated with B A.L. (0.005 M) remained
constant (Table VII A, No. 2). A similar drop has been observed during storage
at 4° C. of extracts not containing B.A.L., i.e. the titre attainable by addition
of B.A.L. to such extracts gradually falls. It seems probable that this effect
is due to the action of tissue proteases.
The effect of tryptic digestion on extracts of normal mouse tissues was also
tried. It is difficult to obtain such extracts with haemagglutinating titres high
enough to make this test satisfactory. In an experiment in which a mouse
embryo extract with a haemagglutinating titre for rabbit cells of 1:4 was digested
with trypsin, with and without B.A.L., activity appeared to be destroyed inHAEMAGGLUTINATION BY EXTRACTS OF TUMOURS
both cases. However, not much reliance can be placed on this result, because
haemolysis by trypsin was rapid in the low dilutions, and may have masked
haemagglutination.
The results of digestion of tumour extracts suggest that B.A.L. may act as
an inhibitor of proteolysis by trypsin and papain. However, Webb and van
Heyningen (1947) state that B.A.L. (0.0042 M) does not inhibit digestion of
casein by either trypsin or papain, as judged by formol-titration of amino-acid
nitrogen, and in certain circumstances activates papain.
Because of this apparent anomaly, the action of B.A.L. on proteolysis was
examined, using tumour extracts, and casein, as substrates.
A 20 per cent extract of C57 sarcoma in M/15 phosphate buffer pH8 was
incubated (a) alone, (b) with trypsin, (c) with trypsin, and B.A.L. 0.005 M, and
(d) with trypsin and B.A.L. 0.01 M. The former concentration of B.A.L. was
chosen because it has a definite, though sub-maximal, preservative effect on the
haemagglutinating agent, and is approximately equal to that used by Webb
and van Heyningen, the latter because it has the maximal preservative effect.
After 21 hours the mixtures were tested for haemagglutinating power, and their
amino-nitrogen content determined by formol-titration.
In a similar experiment, a 4 per cent solution of casein (" light, soluble,"
British Drug Houses) in M/15 phosphate buffer pH8 was substituted for the
tumour extract. Amino-nitrogen was determined after 1 and 2½ hours' incuba-
tion.
The results of these experiments are given in Table VII B and C. They
show that, with casein as substrate, after 1 hour's incubation there was no
detectable inhibition ofproteolysis by B.A.L.; but with both casein and tumour
extract as substrates, after 21 hours' incubation there was definite inhibition:
about 50 per cent by B.A.L. 0.005 M, and 60 per cent by 0.01 M. Both concen-
trations of B.A.L. protected the haemagglutinating agent from the action of
trypsin for 21 hours.
The action of crystalline trypsin, kindly supplied by Dr. S. D. Elliott, on the
haemagglutinating power of a tumour extract, with and without B.A.L., was
essentially similar to that of commercial trypsin.
The haemagglutinating agent does not become dialysable through cellophane
after digestion of a B.A.L.-containing tumour extract with trypsin.
Lecithinase: It has been shown by Stone (1946a) that the haemagglutinating
action of lipoids, and of vaccinia and ectromelia viruses, which probably owe
their haemagglutinating action to lipoid components, is destroyed by Cl. welchii
toxin, which contains an active lecithinase.
A sample of partially purified Cl. welchii toxin was kindly supplied by Miss
M. G. Macfarlane. A preliminary test against egg-yolk (the lecitho-vitellin test
of Macfarlane, Oakley and Anderson, 1941) showed that this preparation was
highly active. The addition of B.A.L. (0.01 M) to the substrate greatly retarded
the action of the enzyme, as judged by this test. Accordingly, its action on
tissue extracts not containing B.A.L. was tried. To C57 sarcoma extract,
buffered at pH 7.6 by the addition of borate buffer, and containing CaCl2 0.01 M
(Stone, 1946a), Cl. welchii toxin was added to give a final concentration of 1.2
lecithinase units per c.c. (The unit of lecithinase, defined by Macfarlane and
Knight (1941) is that amount which, under defined conditions, produces 0.1 mg.
acid-soluble P from lecithin in 15 minutes at 37° C.) The mixture was incubated
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power tested. In a similar experiment mouse embryo extract was treated with
the toxin.
The results showed that incubation with lecithinase had no detectable effect
on the''haemagglutinating agents of C57 sarcoma or mouse embryo extracts.
Haemolysis by lecithinase present in the mixtures was not rapid enough, in the
presence ofB.A.L., to interfere with haemagglutination.
Action of heavy metals and oxidizing agents, and its reversal by B.A.L. To
samples of fresh, actively haemagglutinating, sarcoma extract, not containing
B.A.L., CuS0O4 was added, to give final concentrations of M/300 and M/3000.
In both mixtures haemagglutinating activity disappeared within a few seconds;
there was a partial return of activity in the later, but none in the former, after
addition of B.A.L. to 0.01 M. Manganese, cobalt, and ferric salts, had similar
but less powerful effects in the same concentrations, which were also partially
reversible by B.A.L. In order to determine whether the natural inactivation of
the agent is due to the action ofheavy metals, samples ofa fresh sarcoma extract,
not containing B.A.L., were saturated with benzoin-oxime ("' Cupron ") and
8 hydroxy-quinoline respectively. The former substance reacts specifically with
copper, the latter with any heavy metal, forming inactive compounds. The
haemagglutinating activity of these mixtures declined on standing at the same
rate as that of a control. It thus appeared that the presence of heavy metals
was not essential for natural inactivation.
The addition ofvarious oxidizing agents to a fresh sarcoma extract destroyed
or reduced its haemagglutinating activity. Hydrogen peroxide (10 per cent of
"hydrogen peroxide 100 vols." Boots), sodium hypochlorite (10 per cent of a
1 per cent solution-" Milton "), and iodine (M/300) all destroyed the activity
completely, while lower concentrations produced a drop in titre. Activity
was restored, to a degree depending on relative concentrations, by the addition
ofB.A.L.
DISCUSSION.
A number of substances of widely various type and origin have the power
to agglutinate red cells. The list includes serum antibodies (naturally occurring,
acquired, or experimentally induced), many viruses (Hirst, 1941; Nagler, 1942;
Burnet, 1945; Lush, 1943; Burnet and Stone, 1946; Mills and Dochez, 1944),
purified lipoids (Stone, 1946b), bacterial extracts (Keogh, North, and Warburton,
1947), the globulin fraction of egg-white (Commission on Acute Respiratory
Diseases, 1946), some plant proteins such as ricin and abrin, basic proteins such
as protamines and histones, inorganic colloidal acids and bases such as colloidal
silicic acid, and many metallic salts (Landsteiner, 1945). No report has
appeared, as far as the author is aware, of haemagglutination by extracts of
tissues, either normal or neoplastic. Gross (1947, 1948) has described haemolysis
of mouse, but not rabbit, guinea-pig, or human red cells, by extracts of mouse
mammary carcinoma and lymphatic leukaemia tissue, both spontaneous and
grafted, but he does not report the occurrence of haemagglutination. It is
perhaps not surprising that haemagglutination by tissue extracts has not been
hitherto observed, in view of the lability of the agents. It was a fortunate
accident that C57 sarcoma was the first tumour to be examined, extracts ofwhich
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remain active for several hours. But for this, the phenomenon would probably
not have been noticed, for the majority of tumour and normal tissue extracts
examined remain haemagglutinating for a much shorter time, and then only for
rabbit cells. Their study would not have been possible without experience
gained with C57 sarcoma.
The tissue haemagglutinating agents differ from both viruses and lipoids in
various ways. They are labile, while the latter are both fairly stable sub-
stances; their red-cell species specificity is different from that of both lipoids
and viruses; they are unaffected by Cl. welchii toxin, which destroys the
haemaggluthinating power of lipoids and of vaccinia and ectromelia viruses;
their action is unaffected by normal serum, which inhibits that oflipoids but not
that of viruses. In the manner in which temperature affects haemagglutinating
titre they differ from lipoids. A sarcoma extract is absorbed by red cells which
it agglutinates, but the cells, when they redisperse, as they do under certain
conditions, are fully agglutinable by the same agent; red cells agglutinated
by a virus may also redisperse, but are then inagglutinable by that virus, and
often by some others also (Burnet, Beveridge, McEwin and Boake, 1945).
Egg-white is more like the tissue extracts in its haemagglutinating properties
than are the other haemagglutinating substances referred to, particularly in
respect of red cell species range, and effect of temperature on haemagglutinating
titre, but it is not-reported to be labile.
The general properties of the haemagglutinating agent of tumours suggest
that it is a readily oxidizable substance which is active only in the reduced state.
It may be a sulphydryl compound, but there is at present no positive evidence
of this. Neither inactivation by heavy metals, nor by oxidizing agents, is con-
clusive on thispoint. The formermay actbyforming compounds with sulphydryl
groups, or by catalyzing oxidation; the latter may act on sulphydryl or other
oxidizable groups. More evidence is needed, also, before the nature of the
preservative action ofB.A.L. and other sulphydryl compounds can be determined.
However, the fact that other reducing agents, e.g. ascorbic acid, are ineffective,
suggests that preservation is a specific effect ofsulphydryl. Natural inactivation
does not appear to depend on the presence of heavy metals in an active state,
and therefore it is unlikely that its prevention by B.A.L. is due to the latter's
power of combining with them.
The protection of the haemagglutinating agent by B.A.L. from destruction
by proteolytic enzymes is difficult to understand on the basis of available know-
ledge. B.A.L. has been stated not to inhibit the action of trypsin or papain
(Webb and van Heyningen, 1947), but this work has been repeated here, with a
different result. It has been shown that B.A.L. 0.005 M produces 50 per cent
inhibition of proteolysis of casein, or tumour extract, incubated with trypsin for
21 hours. During this period B.A.L. protects the haemagglutinating agent from
the action oftrypsin, whereas in the absence of B.A.L. it is completely destroyed.
A fuller understanding of these facts must await the result of further work.
Attempts to find qualitative differences between the haemagglutinating
agents of normal tissues and those of tumours, or between those of different
tumours, have been unsuccessful. The observed differences are either so small
as to be of doubtful significance, or can be regarded as quantitative. Though
the possibility that different types of agent exist has not been excluded, there is
no positive evidence of this at present.
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SUMMARY.
Extracts of mouse tumours agglutinate rabbit, mouse, and some other,
red cells.
Some normal tissue extracts agglutinate rabbit cells; a few agglutinate
mouse cells also. Extracts of mouse embryo, placenta, uterus, testicle, ovary,
voluntary muscle, skin, and large intestine, have slight but d3finite activity,
those of mouse brain, heart, lung, liver, spleen, kidney, thyroid, seminal vesicles,
and lymph glands, have none.
Rabbit red cells are the most sensitive to agglutination of those tested.
Mouse cells are agglutinated to titres four to sixteen times lower than rabbit;
sheep, horse, guinea-pig, human, and fowl cells two to four times lower than
mouse.
The haemagglutinating agents of tumours and of normal tissues lose their
activity rapidly on standing. Addition of sulphydryl compounds, notably
2:3-dimercapto-propanol (B.A.L.) preserves their activity, or regenerates it after
loss. Loss of activity is not prevented by addition of other reducing agents,
or ofenzyme poisons, or by storage in an oxygen-free atmosphere.
Certain physical and chemical properties of the haemagglutinating agent of
tumours are described. Reasons are given for regarding it as an easily oxidizable
substance, active only in the reduced state. It is destroyed by proteolytic
enzymes, but not by lecithinase; B.A.L. protects it from the former.
B.A.L. was found to have definite inhibitory action on proteolysis by trypsin,
and on digestion ofegg-yolk by lecithinase.
The haemagglutinating agents of tumours and of normal tissues differ from
haemagglutinating viruses and lipoids in important respects.
No qualitative differences have been found between the haemagglutinating
agents of different tumours, or between those of tumours and normal tissues.
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UTERINE fibroids have been induced in the guinea-pig by the prolonged
administration of oestrogen (Nelson, 1937a, 1937b; Moricard and Cauchoix,
1938). This finding acquired a more general interest from the point of view of
the tumorigenic action of oestrogen in the body when it was discovered that
fibroids can be elicited in this species not only on the uterus but on multiple
spots ofthe abdominal serosa (Lipschutz and Iglesias, 1938). It was found that
the incidence of these abdominal fibroids can reach up to about 80 per cent or
more in female guinea-pigs to which oestrogen is administered continuously for
three months (Lipschutz, 1942; Lipschutz and Vargas, 1939). Argentine
workers found fibroids on the thoracic side also of the diaphragm in 2 out of
30 animals (Sammartino and Gandolfo, 1940). On the contrary, thoracic
fibroids were extremely rare in our own work; it was the same in the extensive
work of Von Wattenwyl (1944) with oestrogen-induced abdominal fibroids.
The question arises whether the difference in behaviour of the abdominal
and thoracic serosa towards oestrogen is due to a genetically fixed differential
reactivity of the endothelial or subendothelial cells of the two serosal covers, or
to an internal "ambiental" factor as represented by the abdominal serosal
fluid. Results with the experimental proof of the second of these possibilities
are given in the present paper.
The above question seems all the more important on account ofthe following
finding. In the male guinea-pig the inguinal channel remains open throughout
* Part of this material has been used by H. Elgueta for his Thesis of M.D. in 1944, for which
the Award of the "Liga Nacional del Cancer" has been received.